Exploring the cellular mechanisms behind proteasome inhibitor resistance in multiple myeloma and emerging strategies to overcome this challenge in cancer treatment.
Explore SENP1's role in cancer development, its molecular mechanisms, and promising therapeutic targeting strategies in this comprehensive scientific overview.
Emerging research into protein biomarkers in blood offers new ways to predict recovery after spinal cord injuries, with UCH-L1 showing particular promise.
Discover how researchers are targeting the EWS-FLI1 protein in Ewing Sarcoma through deubiquitinase inhibition, offering new hope for childhood cancer treatment.
Discover how TRIM29 reprograms glucose metabolism in colorectal cancer through pyruvate kinase manipulation and the Warburg effect.
Explore the fascinating world of TRIM proteins and their dual therapeutic potential in combating viral infections and central nervous system diseases like Alzheimer's and Parkinson's.
Exploring how RFWD2, an E3 ubiquitin ligase, drives multiple myeloma progression and proteasome inhibitor resistance through P27 degradation.
Discover the groundbreaking research revealing how galectin-3 interacts with BARD1 to influence DNA damage repair and cancer treatment resistance.
Discover how Parkin-mediated mitophagy protects kidney cells from fatty acid damage through cellular quality control mechanisms and potential therapeutic applications.
Explore the fascinating world of ubiquitin and ubiquitin-like signals - the sophisticated cellular communication system that regulates protein function and holds therapeutic promise.